Pedro C Barata

65PUBLICATIONS
357CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Sep 05, 2026
Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.

|Aug 18, 2026
Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.

|Jul 01, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|May 21, 2026
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma.

|Mar 25, 2026
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study.

Emmanuel S Antonarakis, Qing Cao, Victoria Catharine

Pageof 11

Frequent Collaborators

13 joint publications

Albert Jang

12 joint publications

Rana R McKay

6 joint publications

Andrew J Armstrong

6 joint publications

Vadim S Koshkin